胃癌中的调节性T细胞:从致病发生到治疗的关键控制者
Ion Negura1, Mariana Pavel-Tanasa2, Mihai Danciu1
1Department of Pathology, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
Cancer treatment reviews
|September 28, 2023
概括
调控性T细胞 (Tregs) 显著影响胃癌 (GC) 的进展和患者的结局. 了解瘤微环境中的Tregs对于开发针对这种侵袭性癌症的有效Treg基疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 胃癌 (GC) 是全球癌症死亡的主要原因,晚期的治疗疗效有限.
- 早期的GC通常是无症状的,使诊断复杂化,导致患者预后不佳.
- 目前的化疗和手术等治疗方法提供了适度的益处,突出了对新治疗策略的需求.
研究的目的:
- 综合审查调节性T细胞 (Tregs) 在胃癌 (GC) 发病,进展和预后中的多方面的作用.
- 探索Tregs作为GC中的预后生物标志物的潜力.
- 评估在GC瘤微环境 (TME) 中准Tregs的治疗潜力.
主要方法:
- 文献综述侧重于调节性T细胞 (Tregs) 和它们与胃癌 (GC) 瘤微环境 (TME) 的相互作用.
- 对Tregs对GC发育,进展和患者结果的影响现有研究的分析.
- 关于免疫检查点抑制剂 (ICI) 在GC中的临床疗效和Tregs的作用的信息综合.
主要成果:
- 调控性T细胞 (Tregs) 是GC瘤微环境 (TME) 中的关键免疫细胞,影响瘤发育和进展.
- Tregs已被确立为胃癌 (GC) 患者的显著预后生物标志物.
- 目前的免疫疗法,如免疫检查点抑制剂 (ICI),在GC中的临床益处是温和的,这表明一个复杂的免疫环境.
结论:
- 调节性T细胞 (Tregs) 在免疫逃避和胃癌 (GC) 的进展中发挥着关键作用.
- 向Tregs为改善GC治疗结果提供了一个有希望的治疗途径.
- 对Tregs和GC TME之间的复杂相互作用进行进一步的研究对于开发有效的基于Treg的疗法至关重要.
更多相关视频
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
404
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
9.9K
相关概念视频
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
